-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US49876K1034 |
| Sector | |
| Industry |
| Market Cap | None |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 2.48 |
| Dividend Yield | None |
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for KLTOW using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026